<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Mathematical Framework • dynamicpv</title>
<!-- favicons --><link rel="icon" type="image/png" sizes="96x96" href="../favicon-96x96.png">
<link rel="icon" type="”image/svg+xml”" href="../favicon.svg">
<link rel="apple-touch-icon" sizes="180x180" href="../apple-touch-icon.png">
<link rel="icon" sizes="any" href="../favicon.ico">
<link rel="manifest" href="../site.webmanifest">
<!-- mathjax math --><script src="https://cdn.jsdelivr.net/npm/mathjax@3.2.2/es5/tex-mml-chtml.js" integrity="sha256-MASABpB4tYktI2Oitl4t+78w/lyA+D7b/s9GEP0JOGI=" crossorigin="anonymous"></script><script>
  window.MathJax = {
    chtml: {
      fontURL: "https://cdn.jsdelivr.net/npm/mathjax@3.2.2/es5/output/chtml/fonts/woff-v2"
    }
  };
</script><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet">
<script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet">
<link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet">
<script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Mathematical Framework">
</head>
<body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">dynamicpv</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.4.1</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto">
<li class="nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="active nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles">
<li><a class="dropdown-item" href="../articles/budget-impact-applications.html">Budget Impact Applications</a></li>
    <li><a class="dropdown-item" href="../articles/cost-effectiveness-applications.html">Cost-Effectiveness Applications</a></li>
    <li><a class="dropdown-item" href="../articles/math-framework.html">Mathematical Framework</a></li>
    <li><a class="dropdown-item" href="../articles/net-present-value.html">Net Present Value</a></li>
  </ul>
</li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul>
<ul class="navbar-nav">
<li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json">
</form></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/MSDLLCpapers/dynamicpv/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul>
</div>


  </div>
</nav><div class="container template-article">




<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="../logo.png" class="logo" alt=""><h1>Mathematical Framework</h1>
            
      
      <small class="dont-index">Source: <a href="https://github.com/MSDLLCpapers/dynamicpv/blob/main/vignettes/math-framework.Rmd" class="external-link"><code>vignettes/math-framework.Rmd</code></a></small>
      <div class="d-none name"><code>math-framework.Rmd</code></div>
    </div>

    
    
<div class="section level2">
<h2 id="introduction-and-motivation">Introduction and Motivation<a class="anchor" aria-label="anchor" href="#introduction-and-motivation"></a>
</h2>
<p>Single cohort cost-effectiveness models are routinely used in the
decision making of Health Technology Assessment (HTA) bodies, and are
widely published in the scientific literature.<span class="citation">(Espinosa et al. 2024; Enright et al. 2025; Do et al.
2021)</span> Despite their utility, such models have been criticised as
overly limited in scope, omitting important elements of value<span class="citation">(Breslau et al. 2023; Shafrin et al. 2024)</span>] and
health equity<span class="citation">(Avanceña and Prosser 2021)</span>.
Anticipated pricing dynamics are routinely ignored, meaning that the
long run opportunity cost for drugs may be misrepresented,<span class="citation">(Neumann et al. 2022)</span> and single cohort modeling
is criticized as not tailored to properly inform decision-making that
will impact future cohorts of patients<span class="citation">(Hoyle and
Anderson 2010)</span>. Case studies have shown how modeling pricing and
uptake as dynamic can have substantial effects on reported Incremental
Cost-Effectiveness Ratio (ICER) values. Without accounting for these
effects, ICERs are overstated and unrepresentative.<span class="citation">(Schöttler et al. 2023; Whittington et al. 2025; Moreno
and Ray 2016)</span></p>
<p>In a recent review, Puls et al listed four challenges in modeling
life cycle drug pricing and offered some proposals.<span class="citation">(Puls et al. 2024)</span> Pricing changes before Loss
of Exclusivity (LoE) events are ‘usually small’ but local pricing data
can be informative, whereas after LoE, changes to pricing ‘should be
informed by country-specific and historical estimates of average price
reductions’, such as may be found in recent reviews.<span class="citation">(Lin et al. 2025; Jofre-Bonet et al. 2025;
Serra-Burriel et al. 2024; Laube et al. 2024)</span> Following earlier
recommendations by by Hoyle and Anderson, cost-effectiveness evaluations
should include future incident cohorts in addition to the present,
prevalent cohort,<span class="citation">(Hoyle and Anderson 2010)</span>
though assumptions may need to be simplified to facilitate calculation.
Reporting should include individual and multiple cohorts, assuming
uniform or utilization-informed weightings.<span class="citation">(Puls
et al. 2024)</span></p>
<p>There are now a growing number of publications of cost-effectiveness
evaluations with dynamic pricing and uptake.<span class="citation">(Puls
et al. 2024; Schöttler et al. 2023; Whittington et al. 2025; Shafrin et
al. 2024; Moreno and Ray 2016)</span> The purpose of this R package is
to provide a simple tool to conduct calculations of present values that
allow for dynamic pricing and dynamic uptake. The mathematical framework
presented in this vignette formalizes what others have developed and
applied,<span class="citation">(Hoyle and Anderson 2010; Shafrin et al.
2024)</span> and provides the technical basis of the calculations within
the <code>dynamicpv</code> package. Other vignettes cover calculations
of Net Present Values, and illustrate how cost-effectiveness and budget
impact models can account for dynamic pricing and uptake. The present
scope of the package is models in discrete time only.</p>
</div>
<div class="section level2">
<h2 id="what-are-dynamic-pricing-and-dynamic-uptake">What are dynamic pricing and dynamic uptake?<a class="anchor" aria-label="anchor" href="#what-are-dynamic-pricing-and-dynamic-uptake"></a>
</h2>
<p><strong>Dynamic pricing</strong> is pricing of a resource
(e.g. acquisition cost of a medicine, wages of a professional) that
changes in time. The opposite of dynamic pricing is static pricing. We
may assume prices are static in nominal terms - they are constant and do
not change value in time at all; or we may assume prices are static in
real terms, in which case, were it not for price inflation, prices would
be constant. Alternatively, pricing can be expected to be quite
irregular - such as when drug prices dramatically reduce after branded
products lose exclusivity. Reflecting these dynamics complicates
calculations of Net Present Value, but is more realistic.</p>
<p><strong>Dynamic uptake</strong> refers to the modeling of multiple
series of payoffs/cashflows over time, rather than the modeling of just
one series of payoffs/cashflows at a time. This may arise, for example,
in considering the treatment costs of multiple cohorts of patients
beginning their treatment courses at different times, leading to the
term ‘stacked cohorts’. There are also analogies to ‘run-off triangles’
used by insurance actuaries to model the emergence of insurance claims
over time following claim events. This is already commonly a
consideration in budget impact models in healthcare, but also relevant
to cost-effectiveness.<span class="citation">(Sullivan et al.
2014)</span></p>
</div>
<div class="section level2">
<h2 id="framework">Framework<a class="anchor" aria-label="anchor" href="#framework"></a>
</h2>
<p>The framework for these calculations is centered around the idea of
costs and outcomes accruing to patients as they receive treatment, or
more generally experience the consequences of an intervention. Time may
be partitioned therefore between the time to begin treatment and the
time since starting treatment.</p>
<p>More formally, suppose <span class="math inline">\(j=1, ...,
J\)</span> indexes the time at which the patient begins treatment
(e.g. a new intervention or Standard of Care, SoC). Suppose <span class="math inline">\(k=1, ..., K\)</span> indexes time since initiating
treatment. Time is <span class="math inline">\(t=j+k-1\)</span>, and we
are interested in <span class="math inline">\(t=1,...,T\)</span>, where
<span class="math inline">\(T\)</span> is the time horizon of the
decision-maker.</p>
<p>This can be illustrated through an example. Suppose then we are
considering a cashflow in timestep <span class="math inline">\(t=3\)</span>. This will comprise:</p>
<ul>
<li>patients who are in the third timestep of treatment that began in
timestep 1, <span class="math inline">\((j,k) = (1, 3)\)</span>;</li>
<li>patients who are in the second timestep of treatment that began in
timestep 2, <span class="math inline">\((j,k) = (2, 2)\)</span>;
and</li>
<li>patients who are in the first timestep of treatment that began in
timestep 3, <span class="math inline">\((j,k) = (3, 1)\)</span>.</li>
</ul>
<p>The Present Value of a cashflow <span class="math inline">\(p_k\)</span> for the <span class="math inline">\(u_j\)</span> patients who began treatment at time
<span class="math inline">\(j\)</span> and who are in their <span class="math inline">\(k\)</span>th timestep of treatment is as
follows</p>
<p><span class="math display">\[ PV(j,k) = u_j \cdot p_k \cdot R_{j+k-1}
\cdot (1+i)^{2-j-k} \]</span></p>
<p>where <span class="math inline">\(i\)</span> is the risk-free
discount rate per timestep, and <span class="math inline">\(p_k\)</span>
is the cashflow amount in today’s money, and <span class="math inline">\(p_k \cdot R_{j+k-1}\)</span> is the nominal amount
of the cashflow at the time it is incurred.</p>
<p>The total present value is therefore the sum over all <span class="math inline">\(j\)</span> and <span class="math inline">\(k\)</span> within the time horizon <span class="math inline">\(T\)</span>. The full function used by the package
allows for additional offsetting of the price uprating factor <span class="math inline">\(R\)</span> by time <span class="math inline">\(l\)</span>. This can be useful for calculating
present values at different present times.</p>
<p><span class="math display">\[ TPV(l) = \sum_{j=1}^{T}
\sum_{k=1}^{T-j+1} PV(j, k, l) = \sum_{j=1}^{T} \sum_{k=1}^{T-j+1} u_j
\cdot p_k \cdot R_{j+k+l-1} \cdot (1+i)^{2-j-k} \]</span></p>
</div>
<div class="section level2">
<h2 id="overview-of-package">Overview of package<a class="anchor" aria-label="anchor" href="#overview-of-package"></a>
</h2>
<p>The <code><a href="../reference/dynpv.html">dynamicpv::dynpv()</a></code> function operationalizes the
formula above. It produces output of the class ‘dynpv’, to which the
following methods may be applied.</p>
<table class="table">
<colgroup>
<col width="28%">
<col width="46%">
<col width="25%">
</colgroup>
<thead><tr class="header">
<th>Method</th>
<th>Description</th>
<th>Value</th>
</tr></thead>
<tbody>
<tr class="odd">
<td><code><a href="https://rdrr.io/r/base/mean.html" class="external-link">mean()</a></code></td>
<td>Mean present value per uptaking patient</td>
<td>
<span class="math inline">\(TPV(l) / \sum_{j=1}^{T} u_j =\)</span>
<code><a href="../reference/total.html">total()</a></code>/<code><a href="../reference/uptake.html">uptake()</a></code>
</td>
</tr>
<tr class="even">
<td><code><a href="../reference/ncoh.html">ncoh()</a></code></td>
<td>Number of cohorts of uptaking patients</td>
<td><span class="math inline">\(n({u_j})\)</span></td>
</tr>
<tr class="odd">
<td><code><a href="../reference/ntimes.html">ntimes()</a></code></td>
<td>Number of times at which present value calculations are
performed</td>
<td><span class="math inline">\(n({l})\)</span></td>
</tr>
<tr class="even">
<td><code><a href="../reference/sum_by_coh.html">sum_by_coh()</a></code></td>
<td>Present value for each uptake cohort <code>j</code> and calculation
time <code>l</code>
</td>
<td><span class="math inline">\(\sum_{k=1}^{T-j+1}
PV(j,k,l)\)</span></td>
</tr>
<tr class="odd">
<td><code><a href="https://rdrr.io/r/base/summary.html" class="external-link">summary()</a></code></td>
<td>Summarize a <code>dynpv</code> object</td>
<td>Text</td>
</tr>
<tr class="even">
<td><code><a href="../reference/total.html">total()</a></code></td>
<td>Total present value</td>
<td><span class="math inline">\(TPV(l)\)</span></td>
</tr>
<tr class="odd">
<td><code><a href="../reference/uptake.html">uptake()</a></code></td>
<td>Total number of uptaking patients</td>
<td><span class="math inline">\(\sum_{j=1}^{T} u_j\)</span></td>
</tr>
</tbody>
</table>
<p>Also, methods <code>+</code> and <code>-</code> can be used to add
and subtract two <code>dynpv</code> objects. It is important to note
when interpreting the <code><a href="https://rdrr.io/r/base/mean.html" class="external-link">mean()</a></code> that the arithmetic operations
add/subtract the <code><a href="../reference/total.html">total()</a></code> and <code><a href="../reference/uptake.html">uptake()</a></code> values
of the objects.</p>
<p>The <code><a href="../reference/futurepv.html">dynamicpv::futurepv()</a></code> function calculates the
present value of a series of payoffs for a single given cohort, entering
at given future time, allowing for dynamic pricing. This function is a
wrapper for <code><a href="../reference/dynpv.html">dynpv()</a></code> restricted to evaluation of a single
cohort.</p>
</div>
<div class="section level2 unnumbered">
<h2 class="unnumbered" id="references">References<a class="anchor" aria-label="anchor" href="#references"></a>
</h2>
<div id="refs" class="references csl-bib-body hanging-indent" entry-spacing="0">
<div id="ref-avancena_2021" class="csl-entry">
Avanceña, Anton L. V., and Lisa A. Prosser. 2021. <span>“Examining
<span>Equity</span> <span>Effects</span> of <span>Health</span>
<span>Interventions</span> in
<span>Cost</span>-<span>Effectiveness</span> <span>Analysis</span>:
<span>A</span> <span>Systematic</span> <span>Review</span>.”</span>
<em>Value in Health</em> 24 (1): 136–43. <a href="https://doi.org/10.1016/j.jval.2020.10.010" class="external-link">https://doi.org/10.1016/j.jval.2020.10.010</a>.
</div>
<div id="ref-breslau_2023" class="csl-entry">
Breslau, Rachel Milstein, Joshua T. Cohen, Jose Diaz, Bill Malcolm, and
Peter J. Neumann. 2023. <span>“A Review of <span>HTA</span> Guidelines
on Societal and Novel Value Elements.”</span> <em>International Journal
of Technology Assessment in Health Care</em> 39 (1): e31. <a href="https://doi.org/10.1017/S026646232300017X" class="external-link">https://doi.org/10.1017/S026646232300017X</a>.
</div>
<div id="ref-do_2021" class="csl-entry">
Do, Lauren A, Patricia G Synnott, Siyu Ma, and Daniel A Ollendorf. 2021.
<span>“Bridging the Gap: Aligning Economic Research with Disease
Burden.”</span> <em>BMJ Global Health</em> 6 (6): e005673. <a href="https://doi.org/10.1136/bmjgh-2021-005673" class="external-link">https://doi.org/10.1136/bmjgh-2021-005673</a>.
</div>
<div id="ref-enright_2025" class="csl-entry">
Enright, Daniel E., Emma G. van Duijnhoven, Daniel A. Ollendorf, and
James D. Chambers. 2025. <span>“Use of Health Technology Assessments in
Specialty Drug Coverage Decisions by <span>US</span> Commercial Health
Plans.”</span> <em>Journal of Managed Care &amp; Specialty Pharmacy</em>
31 (3): 289–95. <a href="https://www.jmcp.org/doi/10.18553/jmcp.2025.31.3.289" class="external-link">https://www.jmcp.org/doi/10.18553/jmcp.2025.31.3.289</a>.
</div>
<div id="ref-espinosa_2024" class="csl-entry">
Espinosa, Oscar, Paul Rodríguez-Lesmes, Giancarlo Romano, Esteban
Orozco, Sergio Basto, Diego Ávila, Lorena Mesa, and Hernán Enríquez.
2024. <span>“Use of <span>Cost</span>-<span>Effectiveness</span>
<span>Thresholds</span> in <span>Healthcare</span> <span>Public</span>
<span>Policy</span>: <span>Progress</span> and
<span>Challenges</span>.”</span> <em>Applied Health Economics and Health
Policy</em> 22 (6): 797–804. <a href="https://doi.org/10.1007/s40258-024-00900-5" class="external-link">https://doi.org/10.1007/s40258-024-00900-5</a>.
</div>
<div id="ref-hoyle_anderson_2010" class="csl-entry">
Hoyle, Martin, and Rob Anderson. 2010. <span>“Whose <span>Costs</span>
and <span>Benefits</span>? <span>Why</span> <span>Economic</span>
<span>Evaluations</span> <span>Should</span> <span>Simulate</span>
<span>Both</span> <span>Prevalent</span> and <span>All</span>
<span>Future</span> <span>Incident</span> <span>Patient</span>
<span>Cohorts</span>.”</span> <em>Medical Decision Making</em> 30 (4):
426–37. <a href="https://doi.org/10.1177/0272989X09353946" class="external-link">https://doi.org/10.1177/0272989X09353946</a>.
</div>
<div id="ref-bonet_2025" class="csl-entry">
Jofre-Bonet, Mireia, Alistair McGuire, Victoria Dayer, Joshua A. Roth,
and Sean D. Sullivan. 2025. <span>“The <span>Price</span>
<span>Effects</span> of <span>Biosimilars</span> in the
<span>United</span> <span>States</span>.”</span> <em>Value in
Health</em> 28 (March): 742–50. <a href="https://doi.org/10.1016/j.jval.2025.02.008" class="external-link">https://doi.org/10.1016/j.jval.2025.02.008</a>.
</div>
<div id="ref-laube_2024" class="csl-entry">
Laube, Y., M. Serra-Burriel, C. C. E. G. Glaus, and K. N. Vokinger.
2024. <span>“Launch and Postlaunch Price Developments of New Drugs in
the US, Germany, and Switzerland.”</span> <em>JAMA Health Forum</em> 5
(11): e244461. <a href="https://doi.org/10.1001/jamahealthforum.2024.4461" class="external-link">https://doi.org/10.1001/jamahealthforum.2024.4461</a>.
</div>
<div id="ref-lin_2025" class="csl-entry">
Lin, Ching-Hsuan, Jonathan D. Campbell, James Motyka, and Joshua T.
Cohen. 2025. <span>“<span>US</span> <span>Drug</span>
<span>Pricing</span> <span>Patterns</span> <span>Before</span>
<span>Loss</span> of <span>Exclusivity</span>.”</span> <em>Value in
Health</em> 28 (6): 907–14. <a href="https://doi.org/10.1016/j.jval.2025.03.008" class="external-link">https://doi.org/10.1016/j.jval.2025.03.008</a>.
</div>
<div id="ref-moreno_2016" class="csl-entry">
Moreno, Santiago G, and Joshua A Ray. 2016. <span>“The Value of
Innovation Under Value-Based Pricing.”</span> <em>Journal of Market
Access and Health Policy</em> 7 (4). <a href="https://doi.org/10.3402/jmahp.v4.30754" class="external-link">https://doi.org/10.3402/jmahp.v4.30754</a>.
</div>
<div id="ref-neumann_2022" class="csl-entry">
Neumann, Peter J., Meghan I. Podolsky, Anirban Basu, Daniel A.
Ollendorf, and Joshua T. Cohen. 2022. <span>“Do
<span>Cost</span>-<span>Effectiveness</span> <span>Analyses</span>
<span>Account</span> for <span>Drug</span> <span>Genericization</span>?
<span>A</span> <span>Literature</span> <span>Review</span> and
<span>Assessment</span> of <span>Implications</span>.”</span> <em>Value
in Health</em> 25 (1): 59–68. <a href="https://doi.org/10.1016/j.jval.2021.06.014" class="external-link">https://doi.org/10.1016/j.jval.2021.06.014</a>.
</div>
<div id="ref-puls_2024" class="csl-entry">
Puls, Mathilde, James Horscroft, Benjamin Kearns, Daniel Gladwell,
Edward Church, Kasper Johannesen, Bill Malcolm, and John Borrill. 2024.
<span>“Challenges of <span>Incorporating</span> <span>Life</span>
<span>Cycle</span> <span>Drug</span> <span>Pricing</span> in
<span>Cost</span>-<span>Effectiveness</span> <span>Models</span>:
<span>A</span> <span>Review</span> of <span>Methods</span> and
<span>Modeling</span> <span>Suggestions</span>.”</span> <em>Value in
Health</em> 27 (7): 978–85. <a href="https://doi.org/10.1016/j.jval.2024.03.006" class="external-link">https://doi.org/10.1016/j.jval.2024.03.006</a>.
</div>
<div id="ref-schottler_2023" class="csl-entry">
Schöttler, Marcel H., Friso B. Coerts, Maarten J. Postma, Cornelis
Boersma, and Mark H. Rozenbaum. 2023. <span>“The <span>Effect</span> of
the <span>Drug</span> <span>Life</span> <span>Cycle</span>
<span>Price</span> on <span>Cost</span>-<span>Effectiveness</span>:
<span>Case</span> <span>Studies</span> <span>Using</span>
<span>Real</span>-<span>World</span> <span>Pricing</span>
<span>Data</span>.”</span> <em>Value in Health</em> 26 (1): 91–98. <a href="https://doi.org/10.1016/j.jval.2022.06.007" class="external-link">https://doi.org/10.1016/j.jval.2022.06.007</a>.
</div>
<div id="ref-serra_2024" class="csl-entry">
Serra-Burriel, M., N. Martin-Bassols, G. Perényi, and K. N. Vokinger.
2024. <span>“Drug Prices After Patent Expirations in High-Income
Countries and Implications for Cost-Effectiveness Analyses.”</span>
<em>JAMA Health Forum</em> 5 (8): e242530. <a href="https://doi.org/10.1001/jamahealthforum.2024.2530" class="external-link">https://doi.org/10.1001/jamahealthforum.2024.2530</a>.
</div>
<div id="ref-shafrin_2024" class="csl-entry">
Shafrin, Jason, Jaehong Kim, Joshua T. Cohen, Louis P. Garrison, Dana A.
Goldman, Jalpa A. Doshi, Joshua Krieger, et al. 2024. <span>“Valuing the
<span>Societal</span> <span>Impact</span> of <span>Medicines</span> and
<span>Other</span> <span>Health</span> <span>Technologies</span>:
<span>A</span> <span>User</span> <span>Guide</span> to
<span>Current</span> <span>Best</span> <span>Practices</span>.”</span>
<em>Forum for Health Economics &amp; Policy</em> 27 (1): 29–116. <a href="https://doi.org/10.1515/fhep-2024-0014" class="external-link">https://doi.org/10.1515/fhep-2024-0014</a>.
</div>
<div id="ref-sullivan_2014" class="csl-entry">
Sullivan, Sean D., Josephine A. Mauskopf, Federico Augustovski, J. Jaime
Caro, Karen M. Lee, Mark Minchin, Ewa Orlewska, Pete Penna, Jose-Manuel
Rodriguez Barrios, and Wen-Yi Shau. 2014. <span>“Budget
<span>Impact</span> <span>Analysis</span>—<span>Principles</span> of
<span>Good</span> <span>Practice</span>: <span>Report</span> of the
<span>ISPOR</span> 2012 <span>Budget</span> <span>Impact</span>
<span>Analysis</span> <span>Good</span> <span>Practice</span>
<span>II</span> <span>Task</span> <span>Force</span>.”</span> <em>Value
in Health</em> 17 (1): 5–14. <a href="https://doi.org/10.1016/j.jval.2013.08.2291" class="external-link">https://doi.org/10.1016/j.jval.2013.08.2291</a>.
</div>
<div id="ref-whittington_2025a" class="csl-entry">
Whittington, Melanie D., Joshua T. Cohen, Peter J. Neumann, Tyler D.
Wagner, and Jonathan D. Campbell. 2025. <span>“Identifying the
<span>Influential</span> <span>Dynamic</span> <span>Inputs</span> in
<span>Cost</span>-<span>Effectiveness</span>
<span>Analyses</span>.”</span> <em>Value in Health</em>, April,
S1098301525022867. <a href="https://doi.org/10.1016/j.jval.2025.03.016" class="external-link">https://doi.org/10.1016/j.jval.2025.03.016</a>.
</div>
</div>
</div>
  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside>
</div>



    <footer><div class="pkgdown-footer-left">
  <p>Developed by Dominic Muston, Merck &amp; Co., Inc., Rahway, NJ, USA and its affiliates.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.2.0.</p>
</div>

    </footer>
</div>





  </body>
</html>
